TRIPLE COMBINATION ANTIBODY THERAPIES

The present invention is directed to triple combination therapies with anti-TIGIT antibodies, anti-PVRIG antibodies, and checkpoint inhibitors, including anti-PD-1 or anti-PD-L1 antibodies.

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	LOGRONIO, Kathryn, LIANG, Spencer, AZULAY, Meir, CHAN, Christopher, KOTTURI, Maya, MACHLENKIN, Arthur, ALTEBER, Zoya, DESAI, Radhika, LEUNG, Ling, OPHIR, Eran, KUMAR, Sandeep, WHELAN, Sarah
Format:	Patent
Sprache:	eng
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention is directed to triple combination therapies with anti-TIGIT antibodies, anti-PVRIG antibodies, and checkpoint inhibitors, including anti-PD-1 or anti-PD-L1 antibodies.